Champions Oncology, Inc. (CSBR) Financials

CSBR Assets vs Liabilities

DateAssetsLiabilities
2024-01-31 26.8 million 28.8 million
2023-10-31 28.3 million 28.2 million
2023-07-31 29.9 million 28.0 million
2023-04-30 34.3 million 29.7 million

CSBR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-01-31 -1.0 million 379000
2023-10-31 436000 53000
2023-07-31 -4.7 million 423000
2023-04-30 -1.5 million 208000

CSBR Net Income

No data available :(

CSBR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-01-31 4.5 million - 7.7 million
2023-10-31 5.5 million - 8.1 million
2023-07-31 4.9 million - 8.4 million
2023-04-30 10.1 million - 8.6 million

CSBR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-01-31 13.6 million
2023-10-31 13.5 million
2023-07-31 13.5 million
2023-04-30 13.6 million

CSBR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-01-31 126000 2.2 million 2.8 million 1.8 million
2023-10-31 153000 2.5 million 2.6 million 1.8 million
2023-07-31 668000 2.8 million 2.9 million 1.7 million
2023-04-30 760000 2.9 million 2.7 million 1.8 million

CSBR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-01-31 12.0 million 7.8 million
2023-10-31 11.6 million 6.6 million
2023-07-31 12.6 million 7.7 million
2023-04-30 13.1 million 7.3 million

CSBR

Price: $4.80

52 week price:
4.17
7.32

Earnings Per Share: -0.72 USD

P/E Ratio: -8.55

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 4300

Ebitda: -4.7 million

Market Capitalization: 67.7 million

Links: